Bottom line
VGHCX vs IDNA: the short answer
VGHCX (Vanguard Health Care Fund) and IDNA (iShares Genomics Immunology and Healthcare ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.
VGHCX is cheaper at 0.33% vs 0.47% — a difference of $14 a year per $10,000 invested.
Over five years, VGHCX returned +6.6% a year vs −4.8% for IDNA (reporting dates differ).
Updated Nov 19, 2026
VGHCX vs IDNA side by side
| VGHCX | IDNA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.33% | 0.47% |
| Annual cost per $10k | $33 | $47 |
| 10-yr cost on $10k (prospectus) | $418 | $591 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +17.3% | −1.0% |
| 5-yr return (annualized) | +6.6% | −4.8% |
| 10-yr return (annualized) | +7.7% | — |
| Best quarter | +16.8% | +41.9% |
| Worst quarter | −12.3% | −21.5% |
| Net assets (fund) | $38.2B | $190.9M |
| Number of holdings | 97 | 61 |
| Portfolio turnover | 47% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VGHCX | IDNA | Difference |
|---|---|---|---|
| 2024 | −1.6% | −1.0% | −0.6% |
| 2023 | +5.4% | −7.8% | +13.2% |
| 2022 | −1.1% | −42.1% | +41.1% |
| 2021 | +14.3% | −4.0% | +18.3% |
| 2020 | +12.6% | +54.5% | −41.9% |
Source: Fund prospectus bar charts
Holdings overlap
5 of VGHCX's top 25 holdings also appear in IDNA's top 25.
| Holding | VGHCX | IDNA |
|---|---|---|
| Merck & Co Inc | 5.44% | 3.91% |
| Gsk Plc | 3.00% | 3.63% |
| Vertex Pharmaceuticals Inc | 2.36% | 3.87% |
| Regeneron Pharmaceuticals Inc | 2.14% | 4.35% |
| Roche Holding AG | 1.18% | 3.85% |
Source: SEC Form N-PORT
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
IDNA top 10
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Regeneron Pharmaceuticals, Inc. — 4.35%
- Genmab A/s — 4.23%
- Incyte Corporation — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Merck & Co., Inc. — 3.91%
FAQ
What is the difference between VGHCX and IDNA?
Which is cheaper, VGHCX or IDNA?
Should I own both VGHCX and IDNA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.